Evidence map›Paper›PMID 29309269›Full record

ReviewThe Permanente journal2018

Hip Osteoarthritis: A Primer.

Michelle J Lespasio, Assem A Sultan, Nicolas S Piuzzi, Anton Khlopas, M Elaine Husni, George F Muschler, Michael A Mont

Registry-linked trialAbstract readReview
In one paragraph

Review in The Permanente journal, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07549386 (Efficacy and Safety of Etoricoxib 90 mg + Diacerein 50 mg Capsule Compared to Meloxicam 15 mg + Diacerein 50 mg in Patients With Knee and/or Hip Osteoarthritis), which is not on this map. Cited by 91 papers, 6 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
91citing papers in PubMed, 6 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07549386 phase3completednot on this mapstarted 2024, after this paper: background citation

Efficacy and Safety of Etoricoxib 90 mg + Diacerein 50 mg Capsule Compared to Meloxicam 15 mg + Diacerein 50 mg in Patients With Knee and/or Hip Osteoarthritis: A Phase III, Controlled, Randomized, Double-blind, Multicenter Clinical Trial.

TypeinterventionalSponsorLaboratorios LiomontRan2024 to 2025Enrolled123ConditionsPain Management, OsteoarthritisArmsEtoricoxib 90 mg + diacerein 50 mg, Meloxicam 15 mg + diacerein 50 mg
3 · Its place in the literature

Who cites it

91 citing papers in PubMed, 6 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Intra-articular hyaluronic acid injections for hip osteoarthritis: a level I systematic review.European journal of orthopaedic surgery & traumatology : orthopedie traumatologie · 2025
    Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Trial
  8. Article
  9. Article
  10. Review
  11. The Thai ICOAP-Hip: Cross-Cultural Adaptation and Validation for Assessing Intermittent and Constant Pain in Hip Osteoarthritis.Journal of the American Academy of Orthopaedic Surgeons. Global research & reviews · 2026
    Article
  12. Review
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

31 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Michelle J LespasioAssistant Professor and Adult Nurse Practitioner in Orthopedic Surgery at the Boston Medical Center in MA. michelle.lespasio@bmc.org.
Assem A SultanClinical Orthopedic Surgery Fellow at the Cleveland Clinic in OH. assem.sultan@gmail.com.
Nicolas S PiuzziOrthopedic Regenerative Medicine and Cellular Therapy Fellow at the Cleveland Clinic in OH. piuzzin@ccf.org.
Anton KhlopasResearch Fellow in Orthopedic Surgery at the Cleveland Clinic in OH. anton.khlopas@gmail.com.
M Elaine HusniRheumatologist and Immunologist and Director of the Arthritis & Musculoskeletal Treatment Center in the Department of Rheumatologic and Immunologic Disease at the Cleveland Clinic in OH. husnie@ccf.org.
George F MuschlerProfessor of Orthopedic Surgery, Director of the Regenerative Medicine Laboratory, and Attending Physician at the Cleveland Clinic in OH. muschlg@ccf.org.
Michael A MontChairman of Orthopedic Surgery at the Cleveland Clinic in OH. montm@ccf.org.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The objective of this article is to deliver a concise up-to-date review on hip osteoarthritis. We describe the epidemiology (disease distribution), etiologies (associated risk factors), symptoms, diagnosis and classification, and treatment options for hip osteoarthritis. A quiz serves to assist readers in their understanding of the presented material.

Indexed as

Osteoarthritis, HipAnalgesics, Non-NarcoticAnti-Inflammatory AgentsArthroplasty, Replacement, HipExercise TherapyHumansPain ManagementPhysical Therapy ModalitiesPrevalenceRisk FactorsSelf-Help DevicesWeight LossAnalgesics, Non-NarcoticAnti-Inflammatory Agents

Identifiers

PMID29309269
PMCPMC5760056

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.